- Home
- EVG
as 07-26-2024 4:00pm EST
Eaton Vance Short Duration Diversified Income Fund is a diversified, closed-end management investment company. Its primary investment objective is to provide a high level of current income with a secondary objective of seeking capital appreciation to the extent consistent with its primary goal. The portfolio of investments consists of business equipment and services, automotive, cable and satellite television, chemicals and plastics, food products, and other areas.
| Founded: | 2005 | Country: | United States |
| Employees: | N/A | City: | N/A |
| Market Cap: | 146.9M | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 49.4K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | Dividend Payout Frequency: | Monthly | |
| EPS: | N/A | EPS Growth: | N/A |
| 52 Week Low/High: | $9.13 - $10.86 | Next Earning Date: | 01-01-0001 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Eaton Vance Short Diversified Income Fund Eaton Vance Short Duration Diversified Income Fund of Beneficial Interest News
EVG Breaking Stock News: Dive into EVG Ticker-Specific Updates for Smart Investing
Associated Press Finance
6 months ago
Bank7: Q4 Earnings Snapshot
Benzinga
6 months ago
I Want To Add An Investment Property To My Retirement Portfolio. Should I Focus On Cash Flow Or Appreciation?
GlobeNewswire
6 months ago
Viscosupplementation Market Predicted to Hit US$ 13.6 Billion in 2032, Riding on a Strong 10.8% CAGR | According to Persistence Market Research
Zacks
6 months ago
Best Momentum Stocks to Buy for January 22nd
GlobeNewswire
7 months ago
U.S. FDA Updates LDL-C Lowering Indication for Esperion’s NEXLETOL® (bempedoic acid) Tablet and NEXLIZET® (bempedoic acid and ezetimibe) Tablet
Zacks
8 months ago
Here's What Key Metrics Tell Us About Ooma (OOMA) Q3 Earnings
Business Wire
8 months ago
Aura Biosciences Announces First Patient Dosed in Global Phase 3 CoMpass Trial Evaluating the Safety and Efficacy of Belzupacap Sarotalocan (Bel-sar) for First-Line Treatment of Early-Stage Choroidal Melanoma
Business Wire
8 months ago
Distribution Dates and Amounts Announced for Certain BlackRock Closed-End Funds
Compare EVG vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "EVG Eaton Vance Short Diversified Income Fund Eaton Vance Short Duration Diversified Income Fund of Beneficial Interest - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.